Michelle Werner
About Michelle Werner
Michelle Werner is the Chief Executive Officer at Alltrna and a CEO Partner at Flagship Pioneering, with over 20 years of experience in the pharmaceutical industry. She has held various leadership roles at major companies, including AstraZeneca and Bristol-Myers Squibb, and serves on the Board of the non-profit organization Rare Disease Renegades.
Work at Alltrna
Michelle Werner serves as the Chief Executive Officer at Alltrna, a position she has held since 2022. In this role, she leads the company's strategic initiatives and operations, focusing on advancing its mission in the biotechnology sector. Her leadership is informed by her extensive experience in the pharmaceutical industry, particularly in oncology and immuno-oncology.
Current Roles and Board Memberships
In addition to her role at Alltrna, Michelle Werner is a CEO Partner at Flagship Pioneering, where she has been active since 2022. She also serves on the Board of Directors at Omega Therapeutics, a position she has held since 2023. Furthermore, she is a member of Chief, a network aimed at supporting women in executive roles, which she joined in 2021.
Education and Expertise
Michelle Werner holds a Bachelor of Arts in Biology and Anthropology from the University of Pennsylvania, earned in 1997. She completed her MBA at the London Business School in 2005. Additionally, she participated in an Executive Education program focused on Women on Boards at Harvard Business School in 2018. Her educational background supports her expertise in market access strategies and leadership in the pharmaceutical industry.
Professional Background
Michelle Werner has over 20 years of experience in the pharmaceutical industry. She has held various leadership roles at major companies, including AstraZeneca and Bristol-Myers Squibb. Her career began in R&D at the Oncology Clinical Trials Unit at Harvard Medical School. She has managed global market access strategies and led franchises in solid tumors and hematology.
Achievements in the Pharmaceutical Industry
Throughout her career, Michelle Werner has held significant positions, including Vice President at AstraZeneca and Director at Bristol-Myers Squibb. She has been involved in managing global franchises and has experience in business planning across multiple therapeutic areas. Her contributions have been recognized within the industry, particularly in oncology and immuno-oncology.